Increased colonic bile acid exposure: a relevant factor for symptoms and treatment in IBS

Abstract

Increased colonic bile acid exposure influences bowel habit and colonic transit time in patients with IBS. A high response rate to open label treatment with colestipol supports this, but placebo-controlled studies are warranted.